Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 16:9:730925.
doi: 10.3389/fbioe.2021.730925. eCollection 2021.

Synthesis and Photothermal Effects of Intracellular Aggregating Nanodrugs Targeting Nasopharyngeal Carcinoma

Affiliations

Synthesis and Photothermal Effects of Intracellular Aggregating Nanodrugs Targeting Nasopharyngeal Carcinoma

Ying Zhong et al. Front Bioeng Biotechnol. .

Abstract

Chemotherapy for the treatment of nasopharyngeal carcinoma (NPC) is usually associated with many side effects; therefore, its treatment options have not yet been completely resolved. Improving distribution to the targeted tumor region and enhancing the cellular uptake of drugs can efficiently alleviate the above adverse medical effects. Near-infrared (NIR) laser light-mediated photothermal therapy (PTT) and photodynamic therapy (PDT) are promising strategies for cancer treatment. In the present study, we developed an efficient multifunctional nanocluster with enhanced targeting and aggregation efficiency for PTT and PDT that is composed of a biocompatible folic acid (FA), indocyanine green (ICG) and 2-cyanobenzothiazole (CBT)-functionalized peptide labeled with an aldehyde sodium alginate-modified magnetic iron oxide nanoparticle (ASA-MNP)-based nanocarrier. FA can bind to folate receptors on cancer cell membranes to enhance nanocluster uptake. CBT-modified peptide can react with glutathione (GSH), which is typically present at higher levels in cancer cells, to form intracellular aggregates and increase the local concentration of the nanodrug. In in vitro studies, these nanodrugs displayed the desired uptake capacity by NPC cells and the ability to suppress the growth of cancer cells under laser irradiation. Animal studies validated that these nanodrugs are safe and nontoxic, efficiently accumulate in NPC tumor sites following injection via the caudal vein, and shows superior inhibition of tumor growth in a tumor-bearing mouse model upon near-infrared laser irradiation. The results indicate the potential application of the multifunctional nanoparticles (NPs), which can be used as a new method for the treatment of folate receptor-positive NPC.

Keywords: folic acid targeting; indocyanine green; intracellular aggregation; nasopharyngeal carcinoma; photothermal effect.

PubMed Disclaimer

Conflict of interest statement

RV was employed by Piramal Pharma Solutions. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Schematic illustration of the construction of FA-PEG/CBT@SPION-ICG and photothermal therapy of nasopharyngeal carcinoma.
FIGURE 2
FIGURE 2
Characterization of FA-PEG@SPION-ICG. TEM images of FA-PEG/CBT@SPION-ICG (i) and FA-PEG/CBT@SPION-ICG after being treated by GSH (ii). DLS diagram of FA-PEG/CBT@SPION-ICG after being treated by GSH (B). UV absorption spectrum of free ICG and FA-PEG/CBT@SPION-ICG (C). In vitro temperature profile (D).
FIGURE 3
FIGURE 3
Prussian blue staining (A) and Hoechst staining (B) (C) of different formations under various conditions. #Stands for p < 0.05 ASA@SPION versus FA-PEG@SPION. $ Stands for p < 0.05 ASA@SPION versus FA-PEG/CBT@SPION. * Stands for p < 0.05 FA-PEG@SPION versus FA-PEG/CBT@SPION. & Stands for p < 0.05 ICG versus FA-PEG/CBT@SPION-ICG. TEM results of HNE-1 cells after cellular uptake of FA-PEG@SPION-ICG and FA-PEG/CBT@SPION-ICG (D). Multimodal small animal imaging after injection of different formations at 8 h (E).
FIGURE 4
FIGURE 4
Calcein-AM/PI live/dead cell staining (10 ×) (A), ROS detected by DCFH-DA staining (B), and western blot analysis (C) of different formations under various conditions. In B, i is PBS, ii is FA-PEG@SPION-ICG, iii is FA-PEG/CBT@SPION-ICG, iv is PBS + Laser, v is ICG + Laser, vi is FA-PEG@SPION-ICG + Laser, and vii is FA-PEG/CBT@SPION-ICG + Laser.
FIGURE 5
FIGURE 5
Thermal imaging of the mice after treatment with different formulations with NIR or MHT (A). Imaging was performed before and on day 2 after the different treatments (B). Tissues dissected from nude mice, mass histogram of the tumor weight, mass histogram of the tumor growth inhibition rate, and a line graph of tumor tissue volume over time (C) (N = 5) (*) p < 0.05 (**) p < 0.01 (***) p < 0.001. Immunohistochemical analysis of Hsp70 expression in different groups (D). Figure 4D, i is PBS, ii is PBS + Laser, iii is FA-PEG/CBT@SPION-ICG, iv is FA-PEG@SPION-ICG + MHT, v is FA-PEG/CBT@SPION-ICG + MHT, vi is free ICG + Laser, vii is FA-PEG@SPION-ICG + Laser, and viii is FA-PEG/CBT@SPION-ICG + Laser.
FIGURE 6
FIGURE 6
Cell viability detected by CCK-8 assay (A). H&E staining of the heart, liver, spleen, lung, kidney, and tumor tissues of nude mice (× 20) (B).

Similar articles

Cited by

References

    1. Aniogo E. C., George B. P. A., Abrahamse H. (2017). In Vitro combined Effect of Doxorubicin and Sulfonated Zinc Phthalocyanine-Mediated Photodynamic Therapy on MCF-7 Breast Cancer Cells. Tumour Biol. 39, 101042831772727. 10.1177/1010428317727278 - DOI - PubMed
    1. Apalla Z., Sotiriou E., Chovarda E., Lefaki I., Devliotou-Panagiotidou D., Ioannides D. (2010). Skin Cancer: Preventive Photodynamic Therapy in Patients with Face and Scalp Cancerization. A Randomized Placebo-Controlled Study. Br. J. Dermatol. 162, 171–175. 10.1111/j.1365-2133.2009.09492.x - DOI - PubMed
    1. Bahmani B., Bacon D., Anvari B. (2013). Erythrocyte-derived Photo-Theranostic Agents: Hybrid Nano-Vesicles Containing Indocyanine green for Near Infrared Imaging and Therapeutic Applications. Sci. Rep. 3, 2180. 10.1038/srep02180 - DOI - PMC - PubMed
    1. Bejjanki N. K., Xu H., Xie M. (2021). GSH Triggered Intracellular Aggregated-Cisplatin-Loaded Iron Oxide Nanoparticles for Overcoming Cisplatin Resistance in Nasopharyngeal Carcinoma. J. Biomater. Appl. 36, 45–54. 10.1177/0885328220982151 - DOI - PubMed
    1. Bourquin C., Pommier A., Hotz C. (2020). Harnessing the Immune System to Fight Cancer with Toll-like Receptor and RIG-I-like Receptor Agonists. Pharmacol. Res. 154, 104192. 10.1016/j.phrs.2019.03.001 - DOI - PubMed